Advanced Drug Development Services (ADDS) is pleased to announce that Dr. Irčne FERMONT, VP Pharmacovigilance & Risk Management, will present a session at the 46th DIA Annual Meeting (June 13-17, 2010 in Washington, DC.)

Dr. Fermont will deliver a presentation on ‘A New Approach to Aggregate Data Analysis and Signal Detection’ (June 14, 3:30pm - 5:00pm, Walter E. Washington Convention Center).

The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and lifecycle management of pharmaceuticals, medical devices, and related products. There is no other industry meeting of its kind that can rival the breadth and depth of experience that this meeting delivers. With 25 content-area tracks, 330 sessions and 20 tutorials, presentations are geared to attendees at all disciplines, works settings, and experience levels.

About the DRUG INFORMATION ASSOCIATION (DIA)

DIA is a neutral, global, professional, member-driven association of nearly 18,000 industry, academia, and regulatory professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.

About Dr. Irčne FERMONT:

Irčne FERMONT, Physician, Immuno-Hematologist and Master of Bioengineering (Ecole Centrale, Paris), has been recognized by the EMEA as a European Qualified Person for Pharmacovigilance (EU-QPPV), and is Eudravigilance certified, allowing an electronic exchange of suspected adverse reaction reports. Her specialisation in Pharmacovigilance makes her a valuable contributor in the field of Pharmacovigilance and Risk Management. More